Please login to the form below

Not currently logged in
Email:
Password:

rights

This page shows the latest rights news and features for those working in and with pharma, biotech and healthcare.

Novartis announces positive phase 3 trial results for advanced oesophageal cancer

Novartis announces positive phase 3 trial results for advanced oesophageal cancer

Through a collaboration and licence agreement with BeiGene, Novartis has the rights to develop, manufacture and commercialise tislelizumab in North America, Europe and Japan.

Latest news

More from news
Approximately 2 fully matching, plus 2,593 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 665 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 291 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 645 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...